Understanding how stroke patients perceive their upper limb use during rehabilitation
Official title: Evolution of the Patient's Perception of the Use of the Upper Limb After a Stroke During Intensive Rehabilitation
Run by Grand Hôpital de Charleroi · NCT06569771 · Data updated 2026-11-12
This study looks at how stroke patients feel about using their affected arm during rehab to see if their thoughts affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Grand Hôpital de Charleroi Academic / other |
| Locations | 2 sites (Charleroi, Hainaut and 1 other locations) |
| Status | Recruiting |
| Started | June 11, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT06569771 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals who have experienced their first stroke and have upper limb weakness as indicated by a specific NIHSS score.
✕Probably not a fit
Patients with a life expectancy of less than 12 months or those with severe pre-existing disabilities affecting arm function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on stroke rehabilitation, specifically examining the relationship between actual upper limb function and patients' perceptions of their ability to use their affected limb. It involves functional assessments to gather data on upper limb performance and the subjective experiences of patients. The goal is to better understand how patients view their participation in rehabilitation activities and how this perception may influence their recovery process.
Why it matters
Potential benefit: If successful, this study could enhance rehabilitation strategies by aligning them more closely with patients' perceptions, potentially improving recovery outcomes.
How similar studies have gone: While this approach is focused on patient perception, similar studies in rehabilitation have shown that understanding patient perspectives can lead to improved treatment outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * First stroke as defined by the World Health Organization. * Upper limb paresis with a NIHSS National Institutes of Health Stroke Scale score \> or = 1/4 for upper limb motor function Exclusion Criteria: * Life expectancy \<12 months * Inability to understand French. * Pre-existing severe multiple disability affecting arm function. * Presence of pre-existing central neurological pathologies. * Mini-Mental State Examination \< 21
Where it's running
-
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium Recruiting -
CHU HELORA site Kennedy
Mons, Hainaut, Belgium Recruiting
Study contacts
- Principal investigator: Maxime Valet, MD — Grand Hôpital de Charleroi
- Study coordinator: Maxime VALET, MD
- Email: Maxime.VALET@ghdc.be
- Phone: 0032 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood samples to test the TST79 molecular test for cancer patients
Doctors will take blood from people with various cancers to see if the TST79 blood test can detect mutations in circulating DNA.
-
AI tool to spot and reduce missed doses of oral medicines for Non-Hodgkin lymphoma patients
This project will try an AI-based system to detect early risks of not taking prescribed oral treatments and alert clinicians for adults with Non-Hodgkin lymphoma treated at Grand Hôpital de Charleroi.
-
Using the JAPET.W+ lumbar exoskeleton to help rehabilitate non-specific mechanical low back pain
This trial will test whether adding the JAPET.W+ lumbar exoskeleton to physiotherapy helps adults with non-specific mechanical low back pain lasting more than six weeks.
-
Observational study on predicting treatment response in diffuse large B-cell lymphoma
This study is trying to see if using machine learning can help doctors predict which patients with diffuse large B-cell lymphoma might not respond to treatment, so they can provide better care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.